GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 mg/ml
Product details
Registration number: SIN11858P
Classification: General Sale List
Active ingredients: SODIUM GLYCEROPHOSPHATE (ANHYDROUS)
Strength: 216 mg/ml
Dosage form: INJECTION
Route: INTRAVENOUS
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
ATC code: B05XA14
HSA approval date: 1 April 2002
Manufacturer(s): HP Halden Pharma AS
Manufacturing country/countries: NORWAY
What are the HSA registration number and classification for GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 mg/ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN11858P
Classification: General Sale List
What active ingredients and strength are recorded for GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 mg/ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: SODIUM GLYCEROPHOSPHATE (ANHYDROUS)
Strength: 216 mg/ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 mg/ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION
Route: INTRAVENOUS
Who is the recorded registrant for GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 mg/ml?
According to the HSA dataset updated 7 August 2026:
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 mg/ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): HP Halden Pharma AS
Manufacturing country/countries: NORWAY
Where can I look up GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 mg/ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN11858P or the exact product name GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 mg/ml. The general register link does not preselect this product.
What are the source dates for this GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 mg/ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 mg/ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN11858P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)